Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Viruses 2010, 2(7), 1382-1393; doi:10.3390/v2071382
Review

Targeting microRNA-122 to Treat Hepatitis C Virus Infection

Received: 31 May 2010; in revised form: 28 June 2010 / Accepted: 2 July 2010 / Published: 5 July 2010
(This article belongs to the Special Issue Antivirals Against Hepatitis C Virus)
View Full-Text   |   Download PDF [199 KB, uploaded 5 July 2010]
Abstract: An important host factor for hepatitis C virus (HCV) is microRNA-122 (miR-122). miR-122 is a liver-specific member of a family of small, non-coding RNA molecules known as microRNAs that play major roles in the regulation of gene expression by direct interaction with RNA targets. miR-122 binds directly to two sites in the 5′ untranslated region (UTR) of HCV RNA and positively regulates the viral life cycle. The mechanism by which this regulation occurs is still not fully understood. There has been a great deal of interest in potential therapeutics based on small RNAs, and targeting miR-122 to combat HCV is one of the furthest advanced. Chemical inhibitors of miR-122 can be introduced into mammals intravenously and result in potent and specific knockdown of the microRNA, with no detectable adverse effects on liver physiology. This strategy was recently applied to chimpanzees chronically infected with HCV and resulted in a sustained reduction in viral load in the animals. Inhibition of miR-122 therefore presents a very attractive novel approach to treating HCV, a virus for which improved therapeutics are urgently needed.
Keywords: microRNA-122; hepatitis C virus microRNA-122; hepatitis C virus
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Jopling, C.L. Targeting microRNA-122 to Treat Hepatitis C Virus Infection. Viruses 2010, 2, 1382-1393.

AMA Style

Jopling CL. Targeting microRNA-122 to Treat Hepatitis C Virus Infection. Viruses. 2010; 2(7):1382-1393.

Chicago/Turabian Style

Jopling, Catherine L. 2010. "Targeting microRNA-122 to Treat Hepatitis C Virus Infection." Viruses 2, no. 7: 1382-1393.



Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert